[ad_1]
The Bioentech co-founder said the vaccine remains inadequate compared to the number of people around the world infected with the virus. Therefore, the world will have to go through a difficult time as the vaccine will not have a great impact next winter.
The German biotechnology company Bioentech and the American pharmaceutical company Pfizer are preparing a vaccine against COVID-19.
The two companies said last week that their preliminary third-stage tests showed the vaccine to be 90 percent effective in producing antibodies against the coronavirus. Approximately 43,000 people from different countries participated in the test.
Two doses of the Pfizer and Bioentech vaccines should be given at three week intervals. The vaccine will be administered as a priority to the elderly, paramedics and health personnel. Then the vaccine will be given in stages.
In an interview with the BBC, Professor Shahin said he believed his vaccine would reduce the risk of human-to-human transmission of the virus. Also, if you become infected with Covid-19 after getting the vaccine, you won’t have too many symptoms.
“I am very optimistic about our vaccine,” he said. It is very effective and can greatly reduce coronavirus infections in humans. The infection reduction rate may not be 90 percent, but 50 percent.
“And if that is the case, then it is a significant step forward. We must not forget that if the spread of the epidemic can be halved, it will have dramatic results.”
For the first time, the world hopes to obtain a highly effective vaccine against the coronavirus through Pfizer and Bioentech.
After his announcement, John Bell, a professor of medicine at the University of Oxford, said on Monday: “Maybe this spring people can get back to normal life.”
“I’m probably the first person to be so optimistic about the vaccine. But I say it with enough confidence.”
However, Shahin, a professor of biotechnology, does not expect all to go well in the spring. “If all goes well, vaccines will start later this year or early next year,” he said.
“Our goal is to deliver more than 300 million doses of vaccine around the world by next April. Only then will the situation be like the beginning of work to eradicate the epidemic.”
However, he believes that the big impact will start to fall later. “The hot summer weather will help us,” he said. Because the transmission rate is lower in summer ”.
“But the most important thing is to vaccinate a lot more people before the fall or winter of next year. Complete the work of all the vaccination projects before the fall.”
[ad_2]
